Oncolytic virus and immunogenic cell death in cancer therapy

Tumour Virus Research · Published 2025-11-27 · DOI 10.1016/j.tvr.2025.200333

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.1016/j.tvr.2025.200333

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2025

Related articles

• The interplay between oncolytic viruses, Toll-like receptor signaling, and chemotherapy in overcoming tumor immune tolerance · Frontiers in Cellular and Infection Microbiology · 2026 · Cites or is cited by this article
• Analytical validation and diagnostic performance of the ASCL1/ZNF582 methylation test for detection of high-grade anal intraepithelial neoplasia and anal cancer · Tumour Virus Research · 2023 · Same journal
• DNA methylation at individual CpG-sites of EPB41L3, HTERT and FAM19A4 are useful for detection of cervical high-grade squamous intraepithelial lesions (HSIL) or worse: Analysis of individual CpG-sites outperforms averaging · Tumour Virus Research · 2024 · Same journal
• Human cytomegalovirus UL82 promotes colorectal cancer cell proliferation through inhibiting the ubiquitination of OGDH via ANGPT2 · Tumour Virus Research · 2025 · Same journal
• The oncogenic role of the NSD histone methyltransferases in head and neck and cervical cancers · Tumour Virus Research · 2024 · Same journal
• E4orf1: The triple agent of adenovirus – Unraveling its roles in oncogenesis, infectious obesity and immune responses in virus replication and vector therapy · Tumour Virus Research · 2024 · Same journal
• Interplay between the DNA damage response and the life cycle of DNA tumor viruses · Tumour Virus Research · 2023 · Same journal
• Rapid-onset cancer · Tumour Virus Research · 2025 · Same journal
• Too many cooks in the kitchen: HPV driven carcinogenesis – The result of collaboration or competition? · Tumour Virus Research · 2024 · Same journal
• HPV18E6 and CDK5 virus-host interaction is a prospective therapeutic target for HPV-positive cervical cancer · Tumour Virus Research · 2025 · Same journal